Korean Journal of Clinical Pharmacy (한국임상약학회지)

Korean College Of Clinical Pharmacy (한국임상약학회)
권호 표지
DOI QR코드

DOI QR Code

Development of a Pharmaceutical Care Service Model for Patients with Diabetes in Ambulatory Care Settings

외래환자 대상 당뇨병 약료서비스 모델 개발

  • Received : 2017.03.10
  • Accepted : 2017.03.26
  • Published : 2017.03.31
Download PDF
⟨ Previous Next ⟩

Abstract

The prevalence of diabetes and its related morbidity and mortality are being increased. Despite the advancement of evidence-based pharmacotherapy in the management of diabetes, many patients in our country do not achieve satisfied therapeutic outcomes. Pharmaceutical care service can be defined as a patient-centered clinical service provided by pharmacists to improve therapeutic outcomes and quality of life of patients, by identifying, and preventing or resolving drug-related problems (DRPs). Pharmaceutical care service is interdisciplinary team-based practice, and is provided through collaborative practice agreement (CPA) between one or more physicians and pharmacists. This article describes a model of pharmaceutical care service which can be adopted in our country for patients with diabetes in the ambulatory care settings. With the successful implementation of this service, clinical, economic, and humanistic outcomes of patients will be improved. Therefore, by actively implementing pharmaceutical care service, pharmacist should contribute to the promotion of patients' health and to the advancement of health care delivery system.

Keywords

References

  1. Hepler CD and Strand LM. Opportunity and responsibility in pharmaceutical care. Am J Hosp Pharm 1990;47:533-43.
  2. Hammond RW, Schwartz AH, Campbell MJ, et al. Collaborative drug therapy management by pharmacist-2003. Pharmacotherapy 2003; 23:1210-25. https://doi.org/10.1592/phco.23.10.1210.32752
  3. Bond CA and Raehl CL. Clinical pharmacy services, pharmacy staffing, and adverse drug reactions in United States hospitals. Pharmacotherapy 2006;26:735-47. https://doi.org/10.1592/phco.26.6.735
  4. Bond CA and Raehl CL. Clinical and economic outcomes of pharmacist-managed antiepileptic drug therapy. Pharmacotherapy 2006;26: 369-78.
  5. Gray DR, Garabedian-Ruffalo SM, Chretien SD. Cost-justification of a clinical pharmacist-managed anticoagulation clinic. Drug Intell Clin Pharm 1985;19:575-80. https://doi.org/10.1177/106002808501900716
  6. McGivney MS, Meyer SM, Duncan-Hewitt W, et al. Medication therapy management: Its relationship to patient counseling, disease management, and pharmaceutical care. J Am Pharm Assoc 2007;47:620-28. https://doi.org/10.1331/JAPhA.2007.06129
  7. American Pharmacists Association and National Association of Chain Drug Stores Foundation. Medication management therapy in pharmacy practice: Core elements of an MTM service model (version 2.0). J Am Pharm Assoc 2008;48:341-53. https://doi.org/10.1331/JAPhA.2008.08514
  8. McBane SE, Dopp AL, Abe A, et al. Collaborative drug therapy management and comprehensive medcation manangement-2015. Pharmacotherapy 2015;35:e39-e50. https://doi.org/10.1002/phar.1563
  9. Bluml BM. Definition of medication therapy manangement: development of professionwide consensus. J Am Pharm. Assoc 2005;45:566-72. https://doi.org/10.1331/1544345055001274
  10. American College of Clinical Pharmacy (ACCP). Standards of practice for clinical pharmacists. Pharmacotherapy 2014;34:794-7. https://doi.org/10.1002/phar.1438
  11. Duckworth W, Abraira C, Mortiz T, et al. VADT Investigators. Glucose control and vascular complications in verterans with type 2 diabetes. N Engl J Med 2009;360:129-39. https://doi.org/10.1056/NEJMoa0808431
  12. Patel A, MacMahon S, Chalmers J, et al. ADVANCE Collaborative Group. Intesive blood glucose control and vascular outcomes in patients with type 2 diabetes. N Engl J Med 2008;358:2560-72. https://doi.org/10.1056/NEJMoa0802987
  13. Gerstein HC, Miller ME, Byington RP, et al. Action to Control Cardiovascular Risk in Diabetes Study Group. Effect of intensive glucose lowering in type 2 diabetes. N Engl J Med 2008;358:2545-59. https://doi.org/10.1056/NEJMoa0802743
  14. Al Mazroui NR, Kamal MM, Ghabash NM, Yacout TA, Kole PL, McElnay JC. Influence of pharmaceutical care on health outcomes in patients with type 2 diabetes mellitus. Br J Clin Pharmacol 2009; 67:547-57. https://doi.org/10.1111/j.1365-2125.2009.03391.x
  15. Chan CW, Siu SC, Wong CK, Lee VW. A pharmacist care program: positive impact on cardiac risk in patients with type 2 diabetes. J Cardiovasc Pharmacol Ther 2012;17:57-64. https://doi.org/10.1177/1074248410396216
  16. Choe HM, Mitrovich S, Dubay D, Hayward RA, Krein SL, Vijan S. Proactive case management of high-risk patients with type 2 diabetes mellitus by a clinical pharmacist: a randomized controlled trial. Am J Manag Care 2005;11:253-60.
  17. Chung WW, Chua SS, Lai PS, Chan SP. Effects of a pharmaceutical care model on medication adherence and glycemic control of people with type 2 diabetes. Patient Prefer Adherence 2014;8:1185-94.
  18. Clifford RM, Davis WA, Batty KT, Davis TM. Effect of a pharmaceutical care program on vascular risk factors in type 2 diabetes: the Fremantle Diabetes Study. Diabetes Care 2005;28:771-76. https://doi.org/10.2337/diacare.28.4.771
  19. Cohen LB, Taveira TH, Khatana SA, Dooley AG, Pirraglia PA, Wu WC. Pharmacist-led shared medical appointments for multiple cardiovascular risk reduction in patients with type 2 diabetes. Diabetes Educ 2011;37:801-12. https://doi.org/10.1177/0145721711423980
  20. Farsaei S, Sabzghabaee AM, Zargarzadeh AH, Amini M. Effect of pharmacist-led patient education on glycemic control of type 2 diabetics: a randomized controlled trial. J Res Med Sci 2011;16:43-49.
  21. Jarab AS, Alqudah SG, Mukattash TL, Shattat G, Al-Qirim T. Randomized controlled trial of clinical pharmacy management of patients with type 2 diabetes in an outpatient diabetes clinic in Jordan. J Manag Care Pharm 2012;18:516-26.
  22. Mahwi TO, Obied KA. Role of the pharmaceutical care in the management of patients with type 2 diabetes mellitus. Int J Pharm Sci Res 2013;4:1363-69.
  23. Mourao AO, Ferreira WR, Martins MA, et al. Pharmaceutical care program for type 2 diabetes patients in Brazil: a randomised controlled trial. Int J Clin Pharm 2013;35:79-86. https://doi.org/10.1007/s11096-012-9710-7
  24. Rothman RL, Malone R, Bryant B, et al. A randomized trial of a primary care-based disease management program to improve cardiovascular risk factors and glycated hemoglobin levels in patients with diabetes. Am J Med 2005;118:276-84. https://doi.org/10.1016/j.amjmed.2004.09.017
  25. Scott DM, Boyd ST, Stephan M, Augustine SC, Reardon TP. Outcomes of pharmacist-managed diabetes care services in a community health center. Am J Health Syst Pharm 2006;63:2116-22. https://doi.org/10.2146/ajhp060040
  26. Simpson SH, Majumdar SR, Tsuyuki RT, Lewanczuk RZ, Spooner R, Johnson JA. Effect of adding pharmacists to primary care teams on blood pressure control in patients with type 2 diabetes: a randomized controlled trial. Diabetes Care 2011;34:20-26. https://doi.org/10.2337/dc10-1294
  27. Sriram S, Chack LE, Ramasamy R, Ghasemi A, Ravi TK, Sabzghabaee AM. Impact of pharmaceutical care on quality of life in patients with type 2 diabetes mellitus. J Res Med Sci 2011;16(Suppl 1):S412-18.
  28. Wishah RA, Al-Khawaldeh OA, Albsoul AM. Impact of pharmaceutical care interventions on glycemic control and other health-related clinical outcomes in patients with type 2 diabetes: randomized controlled trial. Diabetes Metab Syndr 2015;9:271-76. https://doi.org/10.1016/j.dsx.2014.09.001
  29. Plaster CP, Melo DT, Boldt V, et al. Reduction of cardiovascular risk in patients with metabolic syndrome in a community health center after a pharmaceutical care program of pharmacotherapy follow-up. Braz J Pharm Sci 2012;48:435-46. https://doi.org/10.1590/S1984-82502012000300010
  30. Malathy R, Narmadha M, Ramesh S, Alvin JM, Dinesh BN. Effect of a diabetes counseling programme on knowledge, attitude and practice among diabetic patients in Erode district of South India. J Young Pharm 2011;3:65-72. https://doi.org/10.4103/0975-1483.76422
  31. Korean Diabetes Association. Diabetes Fact Sheet in Korean 2016. Available from: http://www.diabetes.or.kr/pro/news/admin.php?code=admin&number=1331&mode=vi ew
  32. Smith MA, Nigro SC. The patient-centered medical home. In: Chessman CC, Richardson M, et al, eds. Pharmacotherapy Self-Assessment Program 7th ed. Science and practice of pharmacotherapy. Lenexa, KS: American College of Clinical Pharmacy 2011: 87-102.
  33. MedicalTimes News. 2014-10-15.[Internet] Available at http://www.medicaltimes.com/Users4/News/newsView.html?ID=1092591. accessed 25 Mar, 2017.
  34. Nichols-English G. Poirier S. Optimizing adherence to pharmaceutical care plans. J Am Pharm Assoc 2012;40:475-85.
  35. Conrad P. The meaning of medications: Another look at compliance. Soc Sci Med 1985;20:29-37. https://doi.org/10.1016/0277-9536(85)90308-9
  36. Monte SV, Slazak EM, Albenese NP, et al. Clinical and economic impact of a diabetes clinical pharmacy service program in a university and primary care-based collaboration model. J Am Pharm Assoc 2009;49:200-8. https://doi.org/10.1331/JAPhA.2009.08160
  37. Cranor CW, Bunting BA, Christensen DB. The Asheville Project: Long-term clijncial and economic outcomes of a community pharmacy diabetes care program. J Am Pharm Assoc 2003;43:173-84.